Yasekwa ngo-2009, i-JYMed ngumboneleli wenkonzo ye-peptide ye-CRDMO ekhokelayo kunye nomvelisi we-API yegeneric e-China egxile ekudibaneni kwesiko, uphuhliso lwenkqubo, ubonelelo lwekliniki kunye norhwebo lwezinto ze-peptide. Inkampani iqeshe malunga ne-600+ FTEs, kunye neqela lolawulo eliphambili elenziwe ziingcali ezineminyaka engama-20 yamava kubuchwepheshe bepeptide. I-JYMed isebenza kwiziko elinye le-R&D kunye nezixhobo ezimbini ezinkulu zemveliso yeenjongo ezininzi, ezinomthamo we-peptide wokwenza iitoni ezininzi.

MALUNGA
JYMED

I-JYMed ngumvelisi we-peptide wase-US ohlolwe yi-FDA osebenza ngokukhethekileyo kwiipeptide zokuthambisa, ii-peptide APIs, kunye neepeptides zesiko. Iimveliso zethu ezifakiweyo ziquka i-Semaglutide, i-Liraglutide, i-Tirzepatide, i-Oxytocin, i-GHK, i-GHK-Cu, i-Acetyl Hexapeptide-8, kunye nokunye. Ukuze ufunde ngakumbi, nceda uqhagamshelane nathi ku:

Email: jymed@jymedtech.com

iindaba kunye nolwazi